Just Got Funded.
← All companies

Mito AI just raised $5.4M.

AI for cancer drug decisions

BiotechAI

The round

Raised
$5.4M
Filed
Nov 4, 2026
Based in
Boston, MA
Investors
7 in this round
Legal name
MitoAI Inc.

About Mito AI

The problem

New cancer trials, studies and expert debate pile up faster than any team can read, so strategy reviews take weeks.

The usual way

Analysts spend weeks building each strategy review by hand.

What they built

Mito AI reads trials, papers, guidelines and conference data and turns them into answers with every claim traced to its source.

HelyxOncology AI
ReadsTrials, studies, guidelinesHundreds
AnswersWhich cancers to target nextDecisions
ProofEvery output traced to sourceGoverned

How it works

  1. GatherTrials, papers, conference data
  2. AnalyzeRivals, targets and next steps
  3. ReviewExperts check every source

Traction

< 1 hrfrom new data to a briefingCompany-reported · mitochon.ai

Built for

  • Drug developers
  • Deal teams
  • Medical teams

Their website

mitochon.ai
Mito AI website
mitochon.ai, captured for this episode.

The script

Every scene of the video: the narration, what's on screen, and a still from the final cut.

  1. Scene 1: Hook
    01Hook0-4s
    “Mito AI just raised five point four million dollars.”
    On screen

    $5.4M · AI for cancer drug decisions

  2. Scene 2: The problem
    02The problem4-10s
    “Cancer drug teams face a flood of new trial results, studies and expert debate every week.”
    On screen

    Cancer research moves too fast.

    New trials, studies and expert opinions pile up faster than any team can read.

  3. Scene 3: The usual way
    03The usual way10-14s
    “So analysts spend weeks reading and summarizing it by hand.”
    On screen

    Weeks of manual reading.

    Analysts spend weeks building each strategy review by hand.

  4. Scene 4: The product
    04The product14-20s
    “Mito AI reads it all and turns it into clear answers, with every claim linked to its source.”
    On screen

    Meet Mito AI, answers with sources.

    • Reads Trials, studies, guidelines
    • Answers Which cancers to target next
    • Proof Every output traced to source
  5. Scene 5: How it works
    05How it works20-25s
    “It gathers the evidence, runs the analysis, and experts review answers they can trace.”
    On screen

    How it works.

    1. Gather Trials, papers, conference data
    2. Analyze Rivals, targets and next steps
    3. Review Experts check every source
  6. Scene 6: Proof
    06Proof25-30s
    “Mito AI says it can turn a big conference readout into a briefing in under an hour.”
    On screen

    Weeks of work, in an hour.

    < 1 hr from new data to a briefing

  7. Scene 7: The round
    07The round30-34s
    “That's five point four million dollars, from seven investors.”
    On screen

    Better decisions for cancer care.

    Boston, MA · 7 investors · Founded 2023

  8. Scene 8: Outro
    08Outro34-37s
    “Follow us for a new funded startup every day.”
    On screen

    Tomorrow: another startup that just got funded.

Caption, as posted

AI biotech startup Mito AI just raised $5.4M to help cancer drug teams turn a flood of research into clear, sourced answers.
Follow @just.got.funded for a new funded startup every day.

New cancer trials, studies and expert debate pile up faster than any team can read, so strategy reviews take weeks.
Mito AI reads trials, papers, guidelines and conference data and turns them into answers with every claim traced to its source.

Should AI help decide which cancer drugs get built next? 👇
Send this to someone who works in cancer research.

#oncology #biotech #artificialintelligence #bostonstartups #justgotfunded

Sources